AXS-12 (Reboxetine)

reboxetine · Axsome Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXS-12 (Reboxetine), covering 2025-11-13 to 2025-11-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) [Phase 3]

See pricing